Owkin raises €72.0M Series B round

The investment, consisting of an equity round and upfront fees, will support Owkin's data generation strategy in multiple therapeutic areas, with a focus on multimodal biological data and cardiovascular drug trials.

Source: https://tech.eu/2022/06/08/owkin-bristol-myers-squibb-investment/